6g is a potent, orally available, pan-JAK inhibitor with IC50 values of 2.8, 2.6, 13, and 58 nM for JAK1, JAK2, JAK3, and Tyk2, respectively, which was approved for the treatment of atopic dermatitis in Japan [110]. This evidence concerns the gene JAK1 and atopic eczema.